PIK3CA and neoplasm: Results showed that treatment with VPA significantly enhanced the ability of NK-92 cells on inhibiting the growth of pancreatic cancer xenograft tumors; however, the anti-tumor effect of VPA was partly attenuated by treating the mice with the PI3K inhibitor LY294002 (Figure 5A, B).